作为治疗神经精神疾病的5‐HT1A激动剂的新型替代乳
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
新的乳化合物被确定为血清素5-HT1A受体激活剂. 这些化合物为神经精神疾病提供了潜在的新疗法.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胺5-HT1A受体是治疗神经精神疾病的关键标.
- 对于这些疾病的现有治疗方法有局限性,需要开发新的治疗药物.
更多相关视频
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: MAOIs and Other Agents
Antipsychotic Drugs: Typical and Atypical Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drugs Affecting Neurotransmitter Release or Uptake
CNS Stimulants: Psychedelic Agents
